Related Experiment Video
Updated: Dec 18, 2025

10:48
Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
10.4K
Cell Type-Specific In Vitro Gene Expression Profiling of Stem Cell-Derived Neural Models
James A Gregory1, Emily Hoelzli1, Rawan Abdelaal1
1Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Cells
|June 11, 2020
Summary
Researchers adapted the RiboTag system for cell type-specific RNA analysis in human stem cell models. This method aids in studying brain diseases by isolating RNA from specific cell types in complex cultures.
Area of Science:
- Neuroscience
- Genomics
- Stem Cell Biology
Background:
- Brain disease research increasingly relies on understanding cell-type specific interactions.
- Human-induced pluripotent stem cell (hiPSC)-based models offer physiological relevance but pose challenges in resolving cell-specific molecular changes.
Purpose of the Study:
- To extend the RiboTag system for cell type-specific RNA analysis in various in vitro models.
- To assess the efficacy and limitations of RiboTag in complex cell cultures, including hiPSC-derived neurons.
Main Methods:
- Adaptation of the RiboTag system, which uses an epitope-tagged ribosomal protein (RPL22), for in vitro applications.
- Testing RiboTag in immortalized cell lines, primary mouse astrocytes, and hiPSC-derived neurons.
- Quantification of off-target RNA depletion in mixed-species co-cultures.
Main Results:
- RiboTag enabled significant depletion of off-target RNA (up to 87%) in mixed-species co-cultures.
- Depletion efficiency showed variability across experimental replicates.
- Lower depletion efficiency was observed particularly in hiPSC-derived motor neurons.
Conclusions:
- The RiboTag system is adaptable to diverse in vitro models for cell type-specific RNA studies.
- Variability in depletion efficiency highlights challenges in applying RiboTag to complex hiPSC-derived neuronal cultures.
- Further optimization is needed to maximize RiboTag's potential in intricate cellular systems for brain disease research.

